Oramed Pharmaceuticals (ORMP) Current Leases (2019 - 2026)
Oramed Pharmaceuticals (ORMP) reported Current Leases of $268000.0 for Q1 2026, up 48.07% on a YoY basis from $181000.0 in Q1 2025, and down 5.96% quarter-over-quarter from $285000.0 in Q4 2025.
Oramed Pharmaceuticals (ORMP) Current Leases (2019 - 2026) Analysis & Trends
Oramed Pharmaceuticals has reported Current Leases for 8 years, with the latest figure at $268000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 48.07% year-over-year to $268000.0; the trailing twelve-month figure through Mar 2026 stood at $268000.0 (up 48.07% YoY), and the FY2025 full-year result was $285000.0, up 31.94% from the prior year.
- Current Leases for Q1 2026 stood at $268000.0, down from $285000.0 in the prior quarter.
- The five-year high for Current Leases was $285000.0 in Q4 2025, with the low at $181000.0 in Q1 2025.
- Historically, Current Leases has averaged $245470.6 across 5 years, with a median of $247000.0 in 2022.
- Annual changes were most pronounced in 2025 — Current Leases slipped 28.74% — and 2026, when it surged 48.07%.
- Oramed Pharmaceuticals' Current Leases stood at $247000.0 in 2022, then grew by 8.1% to $267000.0 in 2023, then slipped by 19.1% to $216000.0 in 2024, then surged by 31.94% to $285000.0 in 2025, then fell by 5.96% to $268000.0 in 2026.
- The last three Current Leases figures came in at $268000.0 (Q1 2026), $285000.0 (Q4 2025), and $271000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Oramed Pharmaceuticals | 151.47 Mn | 133.31 Mn | - | 268,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 268,000.00 |
| Dec 31, 2025 | 285,000.00 |
| Sep 30, 2025 | 271,000.00 |
| Jun 30, 2025 | 264,000.00 |
| Mar 31, 2025 | 181,000.00 |
| Dec 31, 2024 | 216,000.00 |
| Sep 30, 2024 | 243,000.00 |
| Jun 30, 2024 | 250,000.00 |
| Mar 31, 2024 | 254,000.00 |
| Dec 31, 2023 | 267,000.00 |
| Sep 30, 2023 | 251,000.00 |
| Jun 30, 2023 | 236,000.00 |
| Mar 31, 2023 | 242,000.00 |
| Dec 31, 2022 | 247,000.00 |
| Sep 30, 2022 | 228,000.00 |
| Jun 30, 2022 | 233,000.00 |
| Mar 31, 2022 | 237,000.00 |
| Nov 30, 2021 | 130,000.00 |
| Aug 31, 2021 | 130,000.00 |
| May 31, 2021 | 129,000.00 |